Day: October 8, 2022

China Saturday criticized the latest U.S. decision to tighten export controls that would make it harder for China to obtain and manufacture advanced computing chips, calling it a violation of international economic and trade rules that will “isolate and backfire” on the U.S.

“Out of the need to maintain its sci-tech hegemony, the U.S. abuses export control measures to maliciously block and suppress Chinese companies,” said Foreign Ministry representative Mao Ning.

“It will not only damage the legitimate rights and interests of Chinese companies, but also affect American companies’ interests,” she said.

Mao also said that the U.S. “weaponization and politicization” of science and technology as well as economic and trade issues will not stop China’s progress.

She was speaking after the U.S. on Friday updated export controls that included adding certain advanced, high-performance computing chips and semiconductor manufacturing equipment to its list, as well as new license requirements for items that would be used in a supercomputer or for semiconductor development in China.

The U.S. said that the export controls were added as part of ongoing efforts to protect U.S. national security and foreign policy interests.

U.S.-China relations have deteriorated in recent years over technology and security issues. The U.S. has implemented a raft of measures and restrictions designed to prevent China from obtaining chip technology, while China has earmarked billions for investment into the production of semiconductors.

The tensions have impacted semiconductor companies in the U.S. and globally which either export chips or manufacture chips in China. Semiconductor companies such as Nvidia and AMD have seen a 40% decline in stock price over the past year.

“We understand the goal of ensuring national security and urge the U.S. government to implement the rules in a targeted way—and in collaboration with international partners—to help level the playing field and mitigate unintended harm to U.S. innovation,” the Semiconductor Industry Association, which represents U.S. semiconductor industry, said in a statement.
…

The city of Philadelphia issued an apology Thursday for the unethical medical experiments performed on mostly Black inmates at its Holmesburg Prison from the 1950s through the 1970s.

The move comes after community activists and families of some of those inmates raised the need for a formal apology. It also follows a string of apologies from various U.S. cities over historically racist policies or wrongdoing in the wake of the nationwide racial reckoning after the killing of George Floyd by a Minneapolis police officer. 

The city allowed University of Pennsylvania researcher Dr. Albert Kligman to conduct the dermatological, biochemical and pharmaceutical experiments that intentionally exposed about 300 inmates to viruses, fungus, asbestos and chemical agents including dioxin — a component of Agent Orange. The vast majority of Kligman’s experiments were performed on Black men, many of whom were awaiting trial and trying to save money for bail, and many of whom were illiterate, the city said.

Kligman, who would go on to pioneer the acne and wrinkle treatment Retin-A, died in 2010. Many of the former inmates would have lifelong scars and health issues from the experiments. A group of the inmates filed a lawsuit against the university and Kligman in 2000 that was ultimately thrown out because of a statute of limitations. 

Philadelphia Mayor Jim Kenney said in the apology that the experiments exploited a vulnerable population, and the impact of that medical racism has extended for generations.

“Without excuse, we formally and officially extend a sincere apology to those who were subjected to this inhumane and horrific abuse. We are also sorry it took far too long to hear these words,” Kenney wrote. 

Last year, the University of Pennsylvania issued a formal apology and took Kligman’s name off some honorifics like an annual lecture series and professorship. The university also directed research funds to fellows focused on dermatological issues in people of color.
…